口腔生物医学 ›› 2023, Vol. 14 ›› Issue (4): 216-223.

• 论著 • 上一篇    下一篇

连补牙周缓释凝胶的制备及其对实验性牙周炎治疗作用的研究

刘若琳1,曹娇1,赵晓丹1,2,刘瑾1,2,李昂1,2*   

  1. 1. 西安交通大学口腔医院陕西省颅颌面精准医学研究重点实验室
    2. 西安交通大学口腔医院牙周科
  • 收稿日期:2023-08-16 修回日期:2023-11-24 出版日期:2023-12-25 发布日期:2023-12-28
  • 通讯作者: 李昂 E-mail:drliang@xjtu.edu.cn
  • 基金资助:
    国家自然科学基金面上项目

Preliminary study on preparation and therapeutic effect of Lianbu sustained-release gel for experimental periodontitis

  • Received:2023-08-16 Revised:2023-11-24 Online:2023-12-25 Published:2023-12-28

摘要: 目的:制备连补牙周缓释凝胶,考察其基本理化性质、释放度及毒理学特性,并评估其治疗实验性牙周炎的药效学作用。方法:通过碱性磷酸酶实验优选连补牙周缓释凝胶制备的处方工艺,获得黄连提取物与骨碎补提取物配伍的最佳质量比。制备载药率分别为2%、4%、6%的连补牙周缓释凝胶,并对其形态、pH、稳定性、体外释放率等指标进行考察,优选最佳载药率。采用最大耐受量法按20 g/kg给予昆明种小鼠灌胃进行急性毒理实验。构建SD大鼠下唇黏膜盲袋,注入缓释凝胶,涂抹区域牙龈黏膜进行局部黏膜刺激实验。SD大鼠连续灌胃90 d进行长期毒理实验,观察血常规及组织病理学指标。建立SD大鼠实验性牙周炎模型,利用Micro-CT观察大鼠牙槽骨的三维形态,测算釉牙骨质界至牙槽嵴顶(CEJ-ABC)的距离。结果:黄连提取物与骨碎补提取物配伍最佳质量比为1∶10。2%、4%、6%载药率的连补牙周缓释凝胶均具有良好的可注射性,pH均在中性范围,稳定性良好,其中6%连补凝胶释放效果最好。给予小鼠6%缓释凝胶,未见急性毒副反应。黏膜接触实验未见明显的红斑、水肿等刺激性反应。长期毒理实验显示,与对照组和空白凝胶组比较,6%连补牙周缓释凝胶组大鼠的体质量增长、血液学均未见差异,各脏器病理学检查均未见明显的病理变化,说明药物无明显毒副作用。治疗实验性牙周炎大鼠4周后,Micro-CT影像结果显示,6%连补缓释凝胶组牙槽骨吸收显著改善,CEJ-ABC明显小于空白凝胶组及对照组(P<0.05)。结论:所制备的6%连补牙周缓释凝胶具有优良的理化性质及缓释性能,对实验性牙周炎大鼠具有一定的治疗作用。

Abstract: Objective:Prepare Lianbu sustained-release gel, to examine its basic physicochemical properties, degree of release and toxicological properties, and to evaluate its pharmacodynamic effects in the treatment of experimental periodontitis. Methods:The prescription process for the preparation of Lianbu sustained-release gel was optimized by alkaline phosphatase assay to obtain the optimal mass ratio of the extract of coptis and the extract of rhizome drynariae. Glycerol, glyceryl triacetate, hydroxyethyl cellulose and polyacrylic acid resin were used as gel matrix to prepare Lianbu sustained-release gel with 2%, 4%, and 6% drug-loading rate, and their morphology, pH, stability, and the release rate in vitro were examined to optimize the optimal amount of drug loading. Acute toxicity test in mice at 20 g/kg by gavage using the maximum tolerated dose method. The mucosa of the lower lip of SD rats was sutured into a blind pouch, and then the sustained-release gel was injected into the pouch and applied to their lower gingival mucosa for local mucosal irritation experiments. Long-term toxicology experiments were conducted in SD rats by continuous gavage for 90 days to examine the blood routine and histopathological indexes. An experimental periodontitis model was established in SD rats, and the three-dimensional morphology of the alveolar bone of rats was observed using micro-CT, and the CEJ-ABC was measured. Results:The optimum mass ratio for the preparation of coptis extract and rhizome drynariae extract was 1∶10. The 2%, 4%, and 6% Lianbu sustained-release gel all had good injectability, were in the neutral pH range, and were well stabilized. 6% Lianbu sustained-release gel had the best effect on release. No acute toxic side effects were seen in mice given the sustained-release gel. The mucous membrane contact test did not show any significant irritant reactions such as erythema and edema. Long-term toxicology experiments showed no difference in general activity status, behavioral activities, diet, urine and stool, weight gain, hematology of rats in the Lianbu sustained-release gel group compared with the control group, and no obvious pathological changes were seen in the pathological examination of organs, indicating that the drug had no obvious toxic side effects. After treating experimental periodontitis rats for 4 weeks, micro-CT imaging results showed the alveolar bone resorption was significantly improved in 6% gel group and CEJ-ABC was significantly less than that in blank gel group and control group(P<0.05). Conclusions:The prepared 6% Lianbu sustained-release gel had excellent physicochemical properties and slow-release performance, and had certain therapeutic effects on experimental periodontitis rats.